Valliant laboratories IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Valliant laboratories Limited Financial Information (Restated Consolidated)

Amount in (Rs. Crore)

Period Ended 31 Mar 2023 31 Mar 2022 31 Mar 2021
Reserve of Surplus 67.93 55.18 78.082
Total Assets 212.76 181.81 106.31
Total Borrowings 59.40 60.68 0.35
Fixed Assets 29.18 23.21 19.5
Cash 0.456 20.1 18.937
Net Borrowing 58,94 40.5 -18.56
Revenue 338.77 293.47 183.78
EBITDA 35.091 42.318 50.002
PAT 29.00 27.50 30.59
EPS 8.91 9.52 10.83

Services

Equity Trading with CA Abhay

Option Trading with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

Equity Investment with CA Abhay

Services

Option Trading with CA Abhay

Equity Investment with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

Equity Trading with CA Abhay

onlyfans leakedonlyfan leaksonlyfans leaked videos